639 related articles for article (PubMed ID: 22566887)
1. Chronic inflammation in cancer development.
Multhoff G; Molls M; Radons J
Front Immunol; 2011; 2():98. PubMed ID: 22566887
[TBL] [Abstract][Full Text] [Related]
2. Radiation, inflammation, and immune responses in cancer.
Multhoff G; Radons J
Front Oncol; 2012; 2():58. PubMed ID: 22675673
[TBL] [Abstract][Full Text] [Related]
3. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
Qu X; Tang Y; Hua S
Front Immunol; 2018; 9():563. PubMed ID: 29662489
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
[TBL] [Abstract][Full Text] [Related]
5. Impact of miR-223-3p and miR-2909 on inflammatory factors IL-6, IL-1ß, and TNF-α, and the TLR4/TLR2/NF-κB/STAT3 signaling pathway induced by lipopolysaccharide in human adipose stem cells.
Wu J; Niu P; Zhao Y; Cheng Y; Chen W; Lin L; Lu J; Cheng X; Xu Z
PLoS One; 2019; 14(2):e0212063. PubMed ID: 30807577
[TBL] [Abstract][Full Text] [Related]
6. TNF-α mediated MEK-ERK signaling in invasion with putative network involving NF-κB and STAT-6: a new perspective in glioma.
Ramaswamy P; Goswami K; Dalavaikodihalli Nanjaiah N; Srinivas D; Prasad C
Cell Biol Int; 2019 Nov; 43(11):1257-1266. PubMed ID: 30839135
[TBL] [Abstract][Full Text] [Related]
7. STATs in cancer inflammation and immunity: a leading role for STAT3.
Yu H; Pardoll D; Jove R
Nat Rev Cancer; 2009 Nov; 9(11):798-809. PubMed ID: 19851315
[TBL] [Abstract][Full Text] [Related]
8. Regulation of TNF-α and NF-κB activation through the JAK/STAT signaling pathway downstream of histamine 4 receptor in a rat model of LPS-induced joint inflammation.
Ahmad SF; Ansari MA; Zoheir KM; Bakheet SA; Korashy HM; Nadeem A; Ashour AE; Attia SM
Immunobiology; 2015 Jul; 220(7):889-98. PubMed ID: 25666529
[TBL] [Abstract][Full Text] [Related]
9. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
10. E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets.
Huang Y; Chen R; Zhou J
Curr Cancer Drug Targets; 2016; 16(9):765-772. PubMed ID: 26881929
[TBL] [Abstract][Full Text] [Related]
11. Inflammation: a driving force speeds cancer metastasis.
Wu Y; Zhou BP
Cell Cycle; 2009 Oct; 8(20):3267-73. PubMed ID: 19770594
[TBL] [Abstract][Full Text] [Related]
12. Kaempferol 7-O-β-D-glucoside isolated from the leaves of Cudrania tricuspidata inhibits LPS-induced expression of pro-inflammatory mediators through inactivation of NF-κB, AP-1, and JAK-STAT in RAW 264.7 macrophages.
Lee SB; Shin JS; Han HS; Lee HH; Park JC; Lee KT
Chem Biol Interact; 2018 Mar; 284():101-111. PubMed ID: 29470957
[TBL] [Abstract][Full Text] [Related]
13. Elimination of NF-κB signaling in Vimentin+ stromal cells attenuates tumorigenesis in a mouse model of Barrett's Esophagus.
Anand A; Fang HY; Mohammad-Shahi D; Ingermann J; Baumeister T; Strangmann J; Schmid RM; Wang TC; Quante M
Carcinogenesis; 2021 Apr; 42(3):405-413. PubMed ID: 33068426
[TBL] [Abstract][Full Text] [Related]
14. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
15. Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.
Pratheeshkumar P; Son YO; Divya SP; Roy RV; Hitron JA; Wang L; Kim D; Dai J; Asha P; Zhang Z; Wang Y; Shi X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):230-41. PubMed ID: 25448439
[TBL] [Abstract][Full Text] [Related]
16. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment.
Li L; Yu R; Cai T; Chen Z; Lan M; Zou T; Wang B; Wang Q; Zhao Y; Cai Y
Int Immunopharmacol; 2020 Nov; 88():106939. PubMed ID: 33182039
[TBL] [Abstract][Full Text] [Related]
17. TRAF3IP2, a novel therapeutic target in glioblastoma multiforme.
Alt EU; Barabadi Z; Pfnür A; Ochoa JE; Daneshimehr F; Lang LM; Lin D; Braun SE; Chandrasekar B; Izadpanah R
Oncotarget; 2018 Jul; 9(51):29772-29788. PubMed ID: 30038719
[TBL] [Abstract][Full Text] [Related]
18. Standardized extract of Zingiber zerumbet suppresses LPS-induced pro-inflammatory responses through NF-κB, MAPK and PI3K-Akt signaling pathways in U937 macrophages.
Haque MA; Jantan I; Harikrishnan H; Ghazalee S
Phytomedicine; 2019 Feb; 54():195-205. PubMed ID: 30668369
[TBL] [Abstract][Full Text] [Related]
19. Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer.
Yousif NG; Al-Amran FG; Hadi N; Lee J; Adrienne J
Cytokine; 2013 Jan; 61(1):223-7. PubMed ID: 23107826
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and p53: A Tale of Two Stresses.
Gudkov AV; Gurova KV; Komarova EA
Genes Cancer; 2011 Apr; 2(4):503-16. PubMed ID: 21779518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
